Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Infectious Diseases
|
November 16, 2023
Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised Individuals
Ghady Haidar, Jacob C Hodges, Andrew Bilderback, et al.
Trials
|
May 26, 2021
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization
David T Huang, Erin K McCreary, J Ryan Bariola, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 29, 2022
CD4<sup>+</sup> T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-Dependent
Iulia Popescu, Mark E Snyder, Carlo J Iasella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 18, 2022
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)
Ghady Haidar, Mounzer Agha, Andrew Bilderback, et al.
Contemporary Clinical Trials
|
June 13, 2022
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial
Erin K McCreary, J Ryan Bariola, Tami E Minnier, et al.
JAMA Network Open
|
July 14, 2022
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial
David T Huang, Erin K McCreary, J Ryan Bariola, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
JAMA
|
October 4, 2021
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Lise J Estcourt, Alexis F Turgeon, et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
, , , et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
, , , et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Infectious Diseases
|
November 16, 2023
Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised Individuals
Ghady Haidar, Jacob C Hodges, Andrew Bilderback, et al.
Trials
|
May 26, 2021
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization
David T Huang, Erin K McCreary, J Ryan Bariola, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 29, 2022
CD4<sup>+</sup> T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-Dependent
Iulia Popescu, Mark E Snyder, Carlo J Iasella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 18, 2022
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)
Ghady Haidar, Mounzer Agha, Andrew Bilderback, et al.
Contemporary Clinical Trials
|
June 13, 2022
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial
Erin K McCreary, J Ryan Bariola, Tami E Minnier, et al.
JAMA Network Open
|
July 14, 2022
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial
David T Huang, Erin K McCreary, J Ryan Bariola, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
JAMA
|
October 4, 2021
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Lise J Estcourt, Alexis F Turgeon, et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
, , , et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
, , , et al.
Page
of 3